drug discovery OR stratm
158 Results
Recherche avancée
Afficher
Affiner vos résultats Utilisez les filtres pour affiner votre recherche
Content by Application
Content by Brand
Content by Industry
-
-
Lead Discovery GPCRs | Life Science Research | Merck
Lead discovery G protein coupled receptors (GPCRs) are prominent drug targets for treating hypertension, pain, asthma, neurological and other disorders -
GPCR Membrane Preparations | Life Science Research | Merck
Our membrane preparations have been pharmacologically validated for competitive radioligand binding and/or GTPγS studies for worry-free GPCR assays. -
Lead Discovery Ion Channels | Life Science Research | Merck
Lead discovery Ion Channels are important therapeutic targets for conditions including arrhythmia, hypertension, local anesthesia, pain, stroke, epilepsy, depression, bipolar disorder, COPD, autoimmune -
Purified Phosphatases | Life Science Research | Merck
Our broad portfolio of purified phosphatases include: PP1, PP2s, and PTPs. All of our enzymes are available in quantities sufficient for high throughput screening. -
HTS Kit Selection Guide | Life Science Research | Merck
Browse our HTS kit selection guide and learn more about our HTRF Class I PI 3-Kinase kits, available in both 4-step and 3-step formats to optimise assay volume and throughput for all screening requirements. -
Purified Kinases | Life Science Research | Merck
We have a broad portfolio of purified kinases that includes more than 390 active, inactive and unactivated kinases, phosphatases and the largest available selection of disease-relevant mutants. -
Lead Discovery Kinases & Phosphatases | Life Science Research | Merck
Lead discovery kinases & phosphatases groups are post-translational modifications that regulate many disease states, including cancer, neurodegenerative diseases, diabetes, pain, autoimmunity, and cardiovascular diseases. -
HTRF® Enzyme Assays | Life Science Research | Merck
HTRF® enzyme assays provide a universal method for assaying all Class I PI3-Kinases, Class II PI3-Kinases, and PIPKINS in a homogeneous 384- or 1536-well format. -
Solutions pour le drug discovery et le développement
Speed your time to discovery by leveraging our target profiling services, multiplex and traditional immunoassays, and clinical lab contract services that help you prioritize potential drug candidates, screen many biomarkers simultaneously, and conduct research and clinical studies. Our offerings encompass: drug discovery, target profiling and multiplexing.